72 related articles for article (PubMed ID: 38643245)
21. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
Oda K; Uto H; Mawatari S; Ido A
Clin J Gastroenterol; 2015 Feb; 8(1):1-9. PubMed ID: 25575848
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
[TBL] [Abstract][Full Text] [Related]
24. Indocyanine Green Fluorescence Imaging-Assisted Laparoscopic Radiofrequency Ablation of Hepatocellular Carcinoma.
Jhan CH; Kao WY; Huang YM
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):A19-A20. PubMed ID: 36442725
[No Abstract] [Full Text] [Related]
25. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
[TBL] [Abstract][Full Text] [Related]
26. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan.
Chiang CJ; Jhuang JR; Yang YW; Zhuang BZ; You SL; Lee WC; Chen CJ
JAMA Netw Open; 2022 Jul; 5(7):e2222367. PubMed ID: 35849394
[TBL] [Abstract][Full Text] [Related]
27. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in Japan.
Toyoda H; Kariyama K; Hiraoka A; Tsuji K; Ishikawa T; Hatanaka T; Naganuma A; Yasuda S; Nouso K; Kakizaki S; Kumada T; Innes H; Johnson PJ
Aliment Pharmacol Ther; 2022 Aug; 56(4):694-701. PubMed ID: 35707936
[TBL] [Abstract][Full Text] [Related]
28. Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
Rodríguez M; González-Diéguez ML; Varela M; Cadahía V; Andrés-Vizán SM; Mesa A; Castaño A; Alvarez-Navascués C
Am J Gastroenterol; 2021 Dec; 116(12):2390-2398. PubMed ID: 34569986
[TBL] [Abstract][Full Text] [Related]
29. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
30. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Huang DQ; El-Serag HB; Loomba R
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end.
Muzica CM; Stanciu C; Huiban L; Singeap AM; Sfarti C; Zenovia S; Cojocariu C; Trifan A
World J Gastroenterol; 2020 Nov; 26(43):6770-6781. PubMed ID: 33268960
[TBL] [Abstract][Full Text] [Related]
32. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.
Sarin SK; Kumar M; Eslam M; George J; Al Mahtab M; Akbar SMF; Jia J; Tian Q; Aggarwal R; Muljono DH; Omata M; Ooka Y; Han KH; Lee HW; Jafri W; Butt AS; Chong CH; Lim SG; Pwu RF; Chen DS
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):167-228. PubMed ID: 31852635
[TBL] [Abstract][Full Text] [Related]
33. A global view of hepatocellular carcinoma: trends, risk, prevention and management.
Yang JD; Hainaut P; Gores GJ; Amadou A; Plymoth A; Roberts LR
Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):589-604. PubMed ID: 31439937
[TBL] [Abstract][Full Text] [Related]
34. Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.
Baumeister SE; Schlesinger S; Aleksandrova K; Jochem C; Jenab M; Gunter MJ; Overvad K; Tjønneland A; Boutron-Ruault MC; Carbonnel F; Fournier A; Kühn T; Kaaks R; Pischon T; Boeing H; Trichopoulou A; Bamia C; La Vecchia C; Masala G; Panico S; Fasanelli F; Tumino R; Grioni S; Bueno de Mesquita B; Vermeulen R; May AM; Borch KB; Oyeyemi SO; Ardanaz E; Rodríguez-Barranco M; Dolores Chirlaque López M; Felez-Nobrega M; Sonestedt E; Ohlsson B; Hemmingsson O; Werner M; Perez-Cornago A; Ferrari P; Stepien M; Freisling H; Tsilidis KK; Ward H; Riboli E; Weiderpass E; Leitzmann MF
J Hepatol; 2019 May; 70(5):885-892. PubMed ID: 30582978
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
Marrero JA; Kulik LM; Sirlin CB; Zhu AX; Finn RS; Abecassis MM; Roberts LR; Heimbach JK
Hepatology; 2018 Aug; 68(2):723-750. PubMed ID: 29624699
[No Abstract] [Full Text] [Related]
36. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
37. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
[TBL] [Abstract][Full Text] [Related]
38. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.
Wang YG; Wang P; Wang B; Fu ZJ; Zhao WJ; Yan SL
PLoS One; 2014; 9(5):e95485. PubMed ID: 24830459
[TBL] [Abstract][Full Text] [Related]
40. Mediterranean diet and hepatocellular carcinoma.
Turati F; Trichopoulos D; Polesel J; Bravi F; Rossi M; Talamini R; Franceschi S; Montella M; Trichopoulou A; La Vecchia C; Lagiou P
J Hepatol; 2014 Mar; 60(3):606-11. PubMed ID: 24240052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
